Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia.
about
Folate receptor-β constitutes a marker for human proinflammatory monocytesTargeted drug delivery via folate receptors in recurrent ovarian cancer: a reviewStructures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition'Acute myeloid leukemia: a comprehensive review and 2016 update'Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta.Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis.Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia.Insight into nanoparticle cellular uptake and intracellular targetingFolate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis.Mechanisms of membrane transport of folates into cells and across epithelia.Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acid.The ABCs of membrane transporters in health and disease (SLC series): introduction.Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors.Rheumatoid arthritis and tumor necrosis factor alpha.Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.Pharmacogenetics and folate metabolism -- a promising direction.mRNA instability in the nucleus due to a novel open reading frame element is a major determinant of the narrow tissue specificity of folate receptor alpha.Receptor induction and targeted drug delivery: a new antileukaemia strategy.Resistance to antifolates.Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cellsFolic acid inhibits COLO-205 colon cancer cell proliferation through activating the FRα/c-SRC/ERK1/2/NFκB/TP53 pathway: in vitro and in vivo studies.Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal CancerAssessment of folate receptor-β expression in human neoplastic tissues.Targeted Proteomics Enables Simultaneous Quantification of Folate Receptor Isoforms and Potential Isoform-based Diagnosis in Breast Cancer.Novel Therapy for Atherosclerosis Using Recombinant Immunotoxin Against Folate Receptor β-Expressing MacrophagesHigh-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity.Prospects in folate receptor-targeted radionuclide therapyPreparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.Regulation of folate receptor 1 gene expression in the visceral endoderm.Enhanced receptor-mediated endocytosis and cytotoxicity of a folic acid-desacetylvinblastine monohydrazide conjugate in a pemetrexed-resistant cell line lacking folate-specific facilitative carriers but with increased folate receptor expressionClinical translation of folate receptor-targeted therapeutics.Targeted drug delivery to macrophages.In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinoma.Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.Folate Receptor β Regulates Integrin CD11b/CD18 Adhesion of a Macrophage Subset to Collagen.Uptake of etoposide in CT-26 cells of colorectal cancer using folate targeted dextran stearate polymeric micelles.Folate Receptor-Targeted Diagnostics and Therapeutics for Inflammatory Diseases.Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells.Smart Human-Serum-Albumin-As2 O3 Nanodrug with Self-Amplified Folate Receptor-Targeting Ability for Chronic Myeloid Leukemia Treatment.
P2860
Q24300693-728733B2-DF87-41CA-9A91-D909C7EDCF3AQ26828581-5CA9FA7D-DE95-49BA-999C-171248BB3A04Q27679502-9DD3CAF9-31DC-4B48-9168-D61FA3CC2A4DQ28072539-C2608781-C836-4A24-8326-28772075B95EQ33858155-0E2AB99A-0447-4DF9-8C69-8F5263F19E86Q33870942-D1619A9D-3ADD-41CE-B6B6-533F5378E0D6Q34071693-44CF5542-F06D-4088-A003-CD6EAAB196B7Q34127625-9FB030DB-E81F-4131-9FFA-5305ACE469E3Q34139674-229FB4DD-96A1-4639-A580-DAED03F4D3B5Q34184787-214E9B5F-BA2B-4DA7-9086-E21577DCC2FEQ34316154-3D344663-7959-4F6C-9652-3A175FD37590Q34333686-77663D32-0400-4D02-957C-7C6B6BB28F5DQ34333704-A6231DAC-0190-4861-B4BE-1B3DEE2E1A53Q34572250-D7001F98-B935-4324-A6D7-414BCAD237A8Q34628862-55DD773A-A1DC-4368-A84A-5513ACD0BA2FQ34658009-5F716581-8D31-43B2-B6F7-3CE5414AF42AQ34673321-7FFA9ADE-6C60-4CE6-AE43-98F272204677Q34741148-0724D55D-36FA-4073-AD8F-B4504C4EAAFBQ35164785-F7B1F77A-8975-4A14-974D-8A65153C1AF4Q35567272-93099983-33A7-4605-A880-747FB42B2C27Q35661999-2A989C14-BFBD-4CC0-A48E-074CAB59C214Q35701974-DDE0BFA5-B4B2-466D-8C6B-C3524AB007F6Q35738875-1569674C-53CB-4AE2-A297-1FCA795DA42AQ35987448-11846646-034F-41B1-978B-D1B036383EF4Q36287593-330AB65F-984E-41ED-840B-8AFE880D2F73Q36366225-1420B2DA-7D09-4FAC-BB30-ABA5DAD0379CQ36957716-F79E325A-7EDA-4FF2-9FD9-F5E1BF1248EDQ37193061-E1B6AF79-40C6-4888-A4DB-7BA6C02A5095Q37251547-4DE7B255-85AF-4EC8-8BF1-B7EE6592EE30Q37317345-B66C3665-0CC0-49CA-A1E1-C9B79671BDE5Q37553497-E907C2C9-7940-4173-A496-D6B34C47D96AQ38015901-65BB0952-0792-44E6-A375-C1859B29E703Q38071672-AC503815-6252-460B-B040-5044929B3BADQ38180615-107174C4-EC42-4A08-8844-CA3B3F815581Q38259956-46F0375F-CA0E-4B50-81BC-1F89469F4315Q38830402-255E97CF-2854-42F5-A401-AD8C73525526Q39009550-19B26AF5-9534-4E00-94F1-B5C189EE05FDQ39062717-06B687FA-3F06-41C2-9BFF-DC9BE5D8BB88Q39788190-BE9A2F97-6C23-4C00-AEB8-D5A016D29259Q40144113-79931166-9C09-495B-967E-7692A2825D48
P2860
Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Folate receptor type beta is a ...... expressed in myeloid leukemia.
@ast
Folate receptor type beta is a ...... expressed in myeloid leukemia.
@en
type
label
Folate receptor type beta is a ...... expressed in myeloid leukemia.
@ast
Folate receptor type beta is a ...... expressed in myeloid leukemia.
@en
prefLabel
Folate receptor type beta is a ...... expressed in myeloid leukemia.
@ast
Folate receptor type beta is a ...... expressed in myeloid leukemia.
@en
P2093
P2860
P1433
P1476
Folate receptor type beta is a ...... expressed in myeloid leukemia.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0142(19990115)85:2<348::AID-CNCR12>3.0.CO;2-4
P407
P577
1999-01-01T00:00:00Z